CVS Health Co. (NYSE:CVS) Shares Sold by Gibraltar Capital Management Inc.

Gibraltar Capital Management Inc. lessened its holdings in CVS Health Co. (NYSE:CVS) by 4.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 154,795 shares of the pharmacy operator’s stock after selling 7,882 shares during the period. CVS Health accounts for about 5.2% of Gibraltar Capital Management Inc.’s investment portfolio, making the stock its 2nd biggest holding. Gibraltar Capital Management Inc.’s holdings in CVS Health were worth $12,223,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CVS. Vanguard Group Inc. raised its holdings in CVS Health by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock worth $8,180,295,000 after acquiring an additional 485,744 shares during the period. FMR LLC increased its holdings in shares of CVS Health by 29.1% during the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock worth $1,919,159,000 after purchasing an additional 6,194,441 shares during the period. Northern Trust Corp increased its holdings in shares of CVS Health by 2.2% during the 3rd quarter. Northern Trust Corp now owns 14,214,296 shares of the pharmacy operator’s stock worth $992,442,000 after purchasing an additional 305,564 shares during the period. Royal Bank of Canada increased its holdings in shares of CVS Health by 2.2% during the 3rd quarter. Royal Bank of Canada now owns 14,136,920 shares of the pharmacy operator’s stock worth $987,041,000 after purchasing an additional 303,512 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of CVS Health by 2.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,717,825 shares of the pharmacy operator’s stock worth $864,821,000 after purchasing an additional 324,391 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 0.4 %

Shares of CVS stock traded up $0.28 during trading hours on Tuesday, hitting $67.73. 13,476,347 shares of the company were exchanged, compared to its average volume of 10,639,692. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The business has a 50 day moving average of $74.05 and a two-hundred day moving average of $73.62. The company has a market capitalization of $85.37 billion, a PE ratio of 10.48, a PEG ratio of 0.89 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter in the prior year, the company posted $1.99 earnings per share. The firm’s revenue was up 11.9% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.93%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

Insider Buying and Selling at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. SVB Leerink initiated coverage on shares of CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price on the stock. Barclays initiated coverage on shares of CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 target price on the stock. Wells Fargo & Company lowered their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Monday, April 8th. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.